Codeine and clinical impairment in samples in which morphine is not detected

European Journal of Clinical Pharmacology

Volumn 58, Issue 12, 2003, Pages 785-789

  Bachs, Liliana ^a   Skurtveit, Svetlana ^b   Mørland, Jørg ^a  

^a Natl Inst of Forensic Toxicology   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Codeine; Impairment; Morphine

Indexed keywords

CODEINE; CYTOCHROME P450 2D6; MORPHINE;

ADULT; AGE; ANALGESIC ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL EXAMINATION; DOSE RESPONSE; DRIVING ABILITY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUNKENNESS; FEMALE; GENDER; GENETIC POLYMORPHISM; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL;

EID: 0037955819     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0561-y     Document Type: Article

References (39)

1. Poulsen L, Brosen K, Arendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH (1996) Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharmacol 51:289-295
2. Yue QY, Alm C, Svensson JO, Sawe J (1997) Quantification of the O- and N-demethylated and the glucuronidated metabolites of codeine relative to the debrisoquine metabolic ratio in urine in ultrarapid, rapid, and poor debrisoquine hydroxylators. Ther Drug Monit 19:539-542
3. Sindrup SH, Brosen K, Bjerring P, Arendt-Nielsen L, Larsen U, Angelo HR, Gram LF (1990) Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin Pharmacol Ther 48:686693
4. Sindrup SH, Brosen K (1995) The pharmacogenetics of codeine hypoalgesia. Pharmacogenetics 5:335-346
5. Caraco Y, Sheller J, Wood AJ (1996) Pharmacogenetic deterruination of the effects of codeine and prediction of drug interactions. J Pharmacol Exp Ther 278:1165-1174
6. Tyndale RF, Droll KP, Sellers EM (1997) Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics 7:375-379
7. Kathiramalainathan K, Kaplan HL, Romach MK, Busto UE, Li NY, Sawe J, Tyndale RF, Sellers EM (2000) Inhibition of cytochrome P450 2D6 modifies codeine abuse liability. J Clin Psychopharmacol 20:435-444
8. Romach MK, Otton SV, Somer G, Tyndale RF, Sellers EM (2000) Cytochrome P450 2D6 and treatment of codeine dependence. J Clin Psychopharmacol 20:43-45
9. Quiding H, Lundqvist G, Boréus LO, Bondeson U, Öhrvik J (1993) Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery. Eur J Clin Pharmacol 44:319-323
10. Sindrup SH, Arendt-Nielsen L, Brosen K, Bjerring P, Angelo HR, Eriksen B, Gram LF (1992) The effect of quinidine on the analgesic effect of codeine. Eur J Clin Pharmacol 42:587-591
11. Hasselstrom J, Yue QY, Sawe J (1997) The effect of codeine on gastrointestinal transit in extensive and poor metabolisers of debrisoquine. Eur J Clin Pharmacol 53:145-148
12. Eckhardt K, Li S, Ammon S, Schanzle G, Mikus G, Eichelbaum M (1998) Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Pain 76:27-33
13. Bradley CM, Nicholson AN (1986) Effects of a mu-opioid receptor agonist (codeine phosphate) on visuo-motor coordination and dynamic visual acuity in man. Br J Clin Pharmacol 22:507-512
14. Linnoila M, Hakkinen S (1974) Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving. Clin Pharmacol Ther 15:368-373
15. Walker DJ, Zacny JP (1998) Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers. Psychopharmacology 140:191-201
16. Redpath JB, Pleuvry BJ (1982) Double-blind comparison of the respiratory and sedative effects of codeine phosphate and (±)-glaucine phosphate in human volunteers. Br J Clin Pharmacol 14:555-558
17. Saarialho-Kere U, Mattita MJ, Seppata T (1986) Pentazocine and codeine: effects on human performance and mood and interactions with diazepam. Med Biol 64:293-299
18. Stacher G, Bauer P, Schneider C, Winklehner S, Schmierer G (1982) Effects of a combination of oral naproxen sodium and Codeine on experimentally induced pain. Eur J Clin Pharmacol 21:485-490
19. Liljequist R (1981) Codeine-induced memory changes: nature and relationship to opiate system. Eur J Clin Pharmacol 20:99-107
20. Chesher GB (1985) The influence of analgesic drugs in road crashes. Accid Anal Prey 17:303-309
21. Drummer O, Chu M, Gerostamoulos J (1999) Involvement of drugs in accident causation. Report of AustRoad Working Group, Southbank, Australia. Victoria Institute of Forensic Medicine and Department of Forensic Medicine
22. Ray WA, Thapa PB, Shorr RI (1993) Medications and the older driver. Clin Geriatr Med 9:413438
23. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH (1994) Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 5:591-598
24. Zacny JP, Lichtor JL, Flemming D, Coalson DW, Thompson WK (1994) A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers. J Pharmacol Exp Ther 268:1-9
25. Bruera E, Macmillan K, Hanson J, MacDonald RN (1989) The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 39:13-16
26. WHO Collaborating Center for Drug Statistics Methodology (2000) Drug consumption in Norway 1996-2000.
27. Christophersen AS, Morland J (1997) Drugged driving, a review based on the experience in Norway. Drug Alcohol Depend 47:125-135
28. Gjerde H, Christophersen AS, Skuterud B, Klemetsen K, Morland J (1990) Screening for drugs in forensic blood samples using EMIT urine assays. Forensic Sci Int 44:179-185
29. Schuberth J, Schuberth J (1989) Gas chromatographic-mass spectrometric determination of morphine, codeine and 6-monoacetylmorphine in blood extracted by solid phase. J Chromatogr 490:444-449
30. Gjerde H, Fongen U, Gundersen H, Christophersen AS (1991) Evaluation of a method for simultaneous quantification of codeine, ethylmorphine and morphine in blood. Forensic Sci Int 51:105-110
31. Rowland T (1995) Absorption and disposition kinetics, 3rd edn. Lippincott Williams & Wilkins, PA, pp 11-34
32. Kuitunen T (1994) Drug and ethanol effects on the clinical test for drunkenness: single doses of ethanol, hypnotic drugs and antidepressant drugs. Pharmacol Toxicol 75:91-98
33. Zacny JP (1995) A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psycopharmacol 3:432-466
34. Mørland J (2000) Driving under the influence of non alcohol drugs. Forensic Sci Rev 12:79-105
35. Drummer O (1994) Drugs in drivers killed in Australian road traffic accidents. Report no. 0594, Melbourne, Australia. Victoria Institute of Forensic Pathology
36. Kay DC, Gorodetzky CW, Martin WR (1967) Comparative effects of codeine and morphine in man. J Pharmacol Exp Ther 156:101-106
37. Poulsen L, Riishede L, Brosen K, Clemensen S, Sindrup SH (1998) Codeine in post-operative pain. Study of the influence of Sparteine phenotype and serum concentrations of morphine and morphine-6-glucuronide. Eur J Clin Pharmacol 54:451-454
38. Vree TB, van Dongen RT, Koopman-Kimenai PM (2000) Codeine analgesia is due to codeine-6-glucuronide, not morphine. Int J Clin Pract 54:395-398
39. Kerr B, Hill H, Coda B, Catogero M, Chapman CR, Hunt E, Buffington V, Mackie A (1991) Concentration-related effects of morphine on cognition and motor control in human subjects. Neuropsychopharmacology 5:157-166